Advertisement
LivaNova PLC

LivaNova PLC (LIVN) Stock Overview

Explore LivaNova PLC’s financial performance, market position, analyst ratings, and future outlook.

LIVNNASDAQ
HealthcareMedical - Devices
$83.43
$2.38(2.94%)
U.S. Market opens in 54h 48m
Advertisement

LivaNova PLC (LIVN)

Meyka AI Score

Z

Key Financials

Market Cap4.6B
P/E Ratio42.18
EPS (TTM)$4.00
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$78.03
3 Months$87.85
1 Year Target$76.95

LIVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LivaNova PLC (LIVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 74.32, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $76.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 42.18 and a market capitalization of 4.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.94%
5-Day Change
6.08%
1-Month Change
10.62%
3-Month Change
31.08%
6-Month Change
32.70%
Year-to-Date (YTD) Change
35.59%
1-Year Change
82.16%
3-Year Change
68.96%
5-Year Change
-3.08%
All-Time (Max) Change
19.31%

Contact Information

44 20 3325 0660
20 Eastbourne Terrace, London, NaN, W2 6LG

Company Facts

29,000 Employees
IPO DateOct 19, 2015
CountryGB
Actively Trading

Frequently Asked Questions